Status:
COMPLETED
Prevalence and Profile of Aspirin Resistance in Hemodialysis Patients
Lead Sponsor:
Northwell Health
Collaborating Sponsors:
Staten Island University Hospital
Conditions:
Aspirin Resistance
Eligibility:
All Genders
18+ years
Brief Summary
Dialysis patient could be more aspirin resistant than the general population based on data from chronic kidney disease patients
Detailed Description
We will try to describe the profile of aspirin resistant patient in hemodialysis patients
Eligibility Criteria
Inclusion
- all hemodialysis patients on aspirin
Exclusion
- low platelets \<100.000
- coagulopathy, bleeding disorders
- patient on plavix
Key Trial Info
Start Date :
June 1 2008
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
November 1 2008
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT00792272
Start Date
June 1 2008
End Date
November 1 2008
Last Update
July 22 2013
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.